MedTrace Logo

Factors Predicting Transformation of Non Severe Pre-eclampsia Into Pre-eclampsia With Severe Features

NCT05152550 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2021-12-29

No results posted yet for this study

Summary

Preeclampsia is a multi-system progressive disorder characterized by the new onset of hypertension and proteinuria, or hypertension and significant end-organ dysfunction with or without proteinuria, in the last half of pregnancy or postpartum. The genesis of the disease is laid down in early pregnancy and is characterized anatomically by abnormal remodeling of the maternal spiral arteries at the placental site.

Conditions

  • Pre-Eclampsia

Interventions

OTHER

Non-severe pre-eclampsia

Cases diagnosed as Non-severe pre-eclampsia after exclusion of severity features.

Sponsors & Collaborators

  • Ahmed Nagy Abdul-Rahman Younis

    lead OTHER

Principal Investigators

  • Mohamed Samy, MD · Ain Shams Maternity Hospital

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2022-03-01
Completion
2022-03-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05152550 on ClinicalTrials.gov